Advertisement
Stockholder proposals must be received by the Corporate Secretary no laterthan December 31, 2009 in order to be considered for inclusion in theCompany's proxy statement relating to the meeting or to be presented at themeeting. Any such proposal should be mailed to: Corporate Secretary,China-Biotics, Inc., 5th Floor, Block 15-1, No. 999 Ningqiao Road, JinqiaoExport Processing Zone, Pudong, Shanghai, 201206, The People's Republic ofChina.
Advertisement
China-Biotics' executives will provide an investor presentation to discussthe Company's growth strategy, business outlook, and financial performance.The Company's management and Board members will also accept questions fromanalysts and investors.
About China-Biotics, Inc.
China-Biotics, Inc., a leading manufacturer of biotechnology products andsupplements, engages in the research, development, marketing and distributionof probiotics dietary supplements. Through its wholly owned subsidiary,Shanghai Shining Biotechnology Co., Ltd., the Company has operations inShanghai. Its proprietary product portfolio contains live microbialnutritional supplements under the "Shining" brand. Currently, the products aresold OTC through large distributors to pharmacies and supermarkets in Shanghai,Jiangsu, and Zhejiang. Currently, China-Biotics is strategically expanding itsproduction capacity of probiotics to meet growing demand in the bulk additivemarket. For more information, please visit http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform Actof 1995: Any statements set forth above that are not historical facts areforward-looking statements that involve risks and uncertainties that couldcause actual results to differ materially from those in the forward-lookingstatements. Such factors include, but are not limited to, the Company'sability to market existing and new products, and changes from anticipatedlevels of sales, future national or regional economic and competitiveconditions, market acceptance of its retail store concept, changes inrelationships with customers, dependence on its flagship product profits andother factors detailed from time to time in the Company's filings with theUnited States Securities and Exchange Commission and other regulatoryauthorities. The Company undertakes no obligation to publicly update or reviseany forward-looking statements, whether as a result of new information, futureevents or otherwise.The time and venue of China-Biotics' Annual Meeting is as follows: Date: Friday, March 5, 2010 Time: 10:30 a.m. (Shanghai Time) Venue: 5th Floor, Block 15-1, No. 999 Ningqiao Road, Jinqiao Export Processing Zone, Pudong, Shanghai, 201206, The People's Republic of China.
SOURCE China-Biotics, Inc.
